Mirae Asset Global ETFs Holdings’s ANI Pharmaceuticals ANIP Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$783K	Buy	9,463 +597	+7%	+$47.9K	﹤0.01%	1759
2026 Q1	$682K	Buy	8,866 +419	+5%	+$32.7K	﹤0.01%	1720
2025 Q4	$667K	Buy	8,447 +30	+0.4%	+$2.6K	﹤0.01%	1744
2025 Q3	$771K	Sell	8,417 -1,547	-16%	-$126K	﹤0.01%	1646
2025 Q2	$650K	Sell	9,964 -1,029	-9%	-$67K	﹤0.01%	1670
2025 Q1	$736K	Buy	10,993 +470	+4%	+$28.1K	﹤0.01%	1649
2024 Q4	$582K	Buy	10,523 +364	+4%	+$20.9K	﹤0.01%	1845
2024 Q3	$606K	Buy	10,159 +2,024	+25%	+$123K	﹤0.01%	1824
2024 Q2	$518K	Buy	+8,135	New	+$528K	﹤0.01%	1809

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ANIP Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its ANI Pharmaceuticals (ANIP) stake by 6.7% in Q2 2026, buying an estimated $47.9K and bringing the position to 9,463 shares worth $783K. The position accounts for ﹤0.01% of the portfolio, ranked #1759.

Mirae Asset Global ETFs Holdings first reported a position in ANIP in Q2 2024 and has held it in 9 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Mirae Asset Global ETFs Holdings held 9,463 shares of ANI Pharmaceuticals worth $783K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 597 ANI Pharmaceuticals shares in Q2 2026, an estimated $47.9K.
ANI Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1759 holding.
Mirae Asset Global ETFs Holdings first reported a position in ANI Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.